Answers are grounded in this paper and cite their sources.
Molecular mechanism underlying glucagon-like peptide-1 exertion of cardioprotective effects in glucagon-like peptide-1 receptor-dependent and -independent manners. Glucagon-like peptide-1 (28-36a) enters coronary artery endothelial cells through macropinocytosis and binds to mitochondrial trifunctional protein-α, shifting substrate utilization to increase adenosine triphosphate production and modulating a adenosine triphosphate-sensor soluble adenylyl cyclase, thereby producing cyclic adenosine monophosphate and activating protein kinase A to exert cytoprotection from oxidative injury.
No takes yet. Share an insight, caveat, or question.
Liu et al. (2020) reported a review. Glucagon-like peptide-1 (28-36a) was evaluated.
Synapse has enriched 10 related papers. Consider them for comparative context: